AstraZeneca advice from national panel delayed by new data on COVID-19 and variants

Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine.